Skip to content

Jazz Pharmaceuticals JAZZ Income Taxes Paid, Net

Income Taxes Paid, Net at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's income taxes paid, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's income taxes paid, net?
Jazz Pharmaceuticals (JAZZ) reported income taxes paid, net of $30.45M in Q4 2025.
How has Jazz Pharmaceuticals's income taxes paid, net changed year-over-year?
Jazz Pharmaceuticals's income taxes paid, net increased by 6.0% year-over-year, from $28.73M to $30.45M.
What is the long-term trend for Jazz Pharmaceuticals's income taxes paid, net?
Over 2 years (2023 to 2025), Jazz Pharmaceuticals's income taxes paid, net has grown at a -17.2% compound annual growth rate (CAGR), from $177.88M to $121.81M.